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Abstract
G protein-coupled receptors (GPCRs) are increasingly recognized to operate from intracellular 
membranes as well as the plasma membrane. The β2-adrenergic GPCR can activate Gs-
linkedcyclic AMP (cAMP) signaling from endosomes. We show here that the homologous human 
β1-adrenergic receptor initiates an internal Gs-cAMP signal from the Golgi apparatus. By 
developing a chemical method to acutely squelch G protein coupling at defined membrane 
locations, we demonstrate that Golgi activation contributes significantly to the overall cellular 
cAMP response. Golgi signalling utilizes a pre-existing receptor pool rather than receptors 
delivered from the cell surface, requiring separate access of extracellular ligands. Epinephrine, a 
hydrophilic endogenous ligand, accesses the Golgi-localized receptor pool by facilitated transport 
requiring the organic cation transporter 3 (OCT3) whereas drugs can access the Golgi pool by 
passive diffusion according to hydrophobicity. We demonstrate marked differences among both 
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agonist and antagonist drugs in Golgi-localized receptor access, and show that β-blocker drugs 
presently used in the clinic differ markedly in ability to antagonize the Golgi signal. We 
propose ’location bias’ as a new principle for achieving functional selectivity of GPCR-directed 
drug action.
Introduction
GPCRs regulate diverse aspects of cellular and physiological responses and are considered 
therapeutic targets for intervening in numerous pathophysiological processes. A long-
standing goal has been to understand how signalling specificity is achieved by a given 
GPCR. One way to achieve signalling specificity is through differential ligand affinity for 
different GPCRs, the long-recognized principle of receptor selectivity. Alternatively, ligands 
that bind the same GPCR can produce different effects by preferentially driving some 
downstream transduction pathways more strongly than others, the more recently recognized 
principle of functional selectivity. The present understanding of how functional selectivity 
occurs mechanistically is through differential stabilization of different GPCR conformational 
state(s) that shift receptor coupling from one G protein or arrestin mediator to another, the 
mechanism of agonist bias1,2.
A new cellular principle for generating functional selectivity has emerged from the 
discovery that various GPCRs initiate signalling from more than one subcellular location. 
For example, β2-adrenoceptors (β2ARs) stimulate a Gs-mediated cAMP response both from 
the plasma membrane and from endosomes after ligand-induced internalization3, with the 
endosome-initiated cAMP signal preferentially coupling to downstream transcriptional 
control4. A number of other GPCRs also signal after endocytosis, and there is now 
considerable evidence supporting the hypothesis that the location of signal initiation can 
affect both the specificity and timing of downstream events5-7. All presently known 
examples of such location bias are based on signalling after ligand-induced endocytosis of 
receptors from the plasma membrane. We wondered if this principle might extend further, 
beyond the realm of receptors that require physical transfer from the cell surface to 
endomembranes and, if so, whether this might reveal additional potential for generating 
functional selectivity in GPCR-directed drug action according to location.
Here we identify such an additional mechanism through study of the β1-adrenoceptor 
(β1AR), a close relative of the β2AR that, unlike the β2AR, internalizes poorly via clathrin-
coated pits after ligand-induced activation 8. We initially assumed that the β1AR would 
provide a counterexample to β2AR, with β1AR initiating signalling only from the plasma 
membrane. We show here that β1ARs not only initiate signaling from the plasma membrane, 
but also from the Golgi apparatus. We directly demonstrate Golgi-localized β1AR and Gs 
activation using conformational biosensor technology and develop a novel strategy to 
acutely and specifically inactivate the Golgi signal, demonstrating that this internal 
membrane pool can contribute significantly to the overall cellular cAMP response elicited 
by β1AR agonists. A remarkable and distinguishing feature of Golgi-localized β1AR 
activation is that it is mediated by a pre-existing Golgi-localized receptor pool, further 
differentiating it from endosome signalling and requiring ligands to access separately. We 
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describe two modes of alternate ligand access to the Golgi-localized membrane pool and 
find, through direct monitoring of β1AR activity, marked differences among drugs presently 
used in the clinic as β-blockers. Our findings reveal a discrete cellular basis for achieving 
functional selectivity in GPCR-directed drug action through location bias and differential 
ligand access.
Results
Golgi-localized β1AR activation by catecholamines
In adult cardiac myocytes endogenous β1AR but not β2AR has been shown to localize in a 
peri-nuclear distribution thought to represent nuclear membrane9. In these cells Golgi 
membranes are closely adjacent to the nuclear membrane, making them difficult to 
definitively resolve by light microscopy10,11, and a fraction of β1AR clearly localize to the 
Golgi in various cell types12. It is not known if the Golgi localized fraction of β1AR 
represents simply a reserve pool or if it also plays a role in catecholamine signalling. To 
address this question, we utilized a biosensor of activated β2AR derived from a 
conformation-specific single-domain camelid antibody (Nb80) 3,13,14. We reasoned that this 
nanobody, which selectively binds the agonist-occupied β2AR, might also recognize 
activated β1AR based on extensive sequence homology in the region recognized by Nb80 
(Supplementary Results, Supplementary Fig 1a). This proved to be the case; in β1AR 
expressing cells maintained in the absence of agonist, Nb80 fused to GFP (Nb80–GFP) 
localized diffusely through out the cytoplasm (Fig. 1a, 0 min, top row). After application of 
the adrenergic endogenous ligand, epinephrine (10 μM) at 37°C, Nb80–GFP was rapidly 
recruited to the plasma membrane (Fig. 1a, 2.5 min, middle row). Nb80–GFP was recruited 
to internal membranes two to three minutes later. Co-localization analysis defined Golgi 
membranes as a major site of epinephrine-induced Nb80-GFP recruitment (Fig. 1a, 20min, 
bottom row, Pearson’s coefficient= 0.67, see also Supplementary Video 1), overlapping the 
pool of Golgi-localized β1AR (Fig 1c). These results suggest that the extracellular ligand 
promotes conformational activation of β1ARs not only the plasma membrane, but also in the 
Golgi apparatus.
To exclude a potential contribution of endogenous β2ARs we used the β1AR selective 
agonist, dobutamine, and pre-treated cells with a β2AR selective antagonist (ICI118551, 
10μM). Robust Nb80-GFP recruitment to Golgi membranes was still observed, verifying 
that Golgi activation is mediated specifically by β1ARs (Fig. 1b, Pearson’s coefficient= 0.71, 
see also Supplementary Video 2).
The data so far suggest that Golgi localized β1AR achieve an activated conformation upon 
extracellular ligand application and shortly after receptor activation on the plasma 
membrane. We next investigated if activation of β1AR at the Golgi requires receptor 
activation on the plasma membrane and whether agonist is delivered to the internal 
membrane via receptor endocytosis. A number of agonists have been demonstrated to co-
internalize with their cognate receptors into the same internal membrane compartment15-17. 
β1ARs, in contrast to β2ARs, display minimal internalization upon activation on the plasma 
membrane (Fig. 1d) 8,18 and this process has recently been proposed to require endophilin 
and dynamin but not clathrin19. To test whether activated β1AR on the Golgi is dependent on 
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β1AR endocytosis from the plasma membrane, we used a dynamin inhibitor, Dyngo-4a, to 
acutely block all dynamin-dependent endocytosis mechanisms. Ligand-induced endocytosis 
of β1AR was undetectable in the presence of Dyngo-4a (Fig. 1d) but ligand-induced 
recruitment of Nb80-mApple to Golgi membranes was still observed (Fig. 1e, Pearson’s 
coefficient= 0.5). This suggests that β1AR activation at the Golgi is independent of its 
activation at the plasma membrane. Supporting this, we found that sotalol, amembrane-
impermeant antagonist that blocks β1AR activation selectively at the plasma membrane, had 
no effect on receptor activation at the Golgi by the membrane-permeant agonist dobutamine 
(Supplementary Fig. 1b, Pearson’s coefficient=0.46). All together, these data suggest that 
β1AR resides on the Golgi at steady state and its activation by the extracellular ligand does 
not require receptor activation or internalization from the plasma membrane.
Golgi-localized β1ARs activate Gs
Because the Golgi-localized β1AR pool can clearly undergo conformational activation, we 
next asked if receptors can activate their cognate G protein, Gs, at the Golgi. Heterotrimeric 
G proteins and adenylyl cyclase can be observed at the Golgi as well as the plasma 
membrane, supporting the concept of Golgi-based G protein signalling20-24. More recently, 
it has been demonstrated that activation of KDEL receptor by cargo transport from the 
endoplasmic reticulum to the Golgi triggers a cascade that involves Gs and adenylyl cyclase 
activation at Golgi membranes25. We observed detectable localization of both over-
expressed and endogenous Gs on the Golgi at steady state (Fig. 2a, Pearson’s 
coefficient=0.62 and 0.48 for overexpressed and endogenous Gs, respectively). To directly 
investigate β1AR-mediated Gs activation at the Golgi, we utilized Nb37-GFP, which 
specifically recognizes a transient intermediate in the process of Gs activation and thus 
serves as a local Gs activation biosensor3,26. Nb37–GFP localized in the cytoplasm of 
untreated cells and was rapidly recruited to the plasma membrane in response to agonist 
application and co-localized there with β1ARs (Fig. 2b, white inset shows higher 
magnification on the right). Nb37–GFP was then recruited to Golgi membranes, with a 
strong signal observed within 20 minutes after agonist application (Fig. 2b, yellow inset 
shows higher magnification on the right; Pearson’s coefficient= 0.33), see also 
Supplementary Video 3 and 4).Golgi-localized Gs activation was indeed mediated by β1ARs 
because it was elicited also by the β1AR-selective agonist dobutamine (Supplementary Fig. 
2a, Pearson’s coefficient=0.6). All together, these data suggest that Gs associates with Golgi 
membranes at steady state and can be activated locally byβ1ARs in response to dobutamine.
Endogenous β1AR localizes at the Golgi and activates Gs
Endogenous β1AR has been shown to localize at the peri-nuclear regions in cardiac 
myocytes9. Additionally, previous studies using both biochemical fractionation and 
immunofluorescence microscopy, have provided evidence for Gs localization at Golgi 
membranes20,24. To ask if activation of endogenous β1AR and Gs can occur at the Golgi, we 
examined H9C2 cells, a rat myoblast cell line that expresses endogenous β1ARs 27. Using an 
antibody recognizing native β1AR, we detected localization both to the plasma membrane 
and to Golgi membranes in H9C2 cells (Fig. 2c top, Pearson’s coefficient=0.55). We verified 
specificity of endogenous receptor detection by knocking down β1AR using two different 
siRNAs (Fig 2c bottom, Pearson coefficient for β1AR si-2 and 3 = 0.26 and 0.29 
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respectively, full images of blots are shown in supplementary Fig 3a). Importantly, both 
Nb80-GFP and Nb37-GFP were recruited to Golgi upon addition of the β1AR-selective 
agonist dobutamine (Fig. 2d top and bottom panels, respectively; also see Supplementary 
Fig 2b), as verified quantitatively by Pearson’s correlation analysis of Nb80-GFP or Nb37-
GFP localization relative to Golgi marker calculated before and after addition of dobutamine 
(Supplementary Fig 3 b and c). All together, these results indicate that endogenous β1ARs 
reside in the Golgi apparatus and can activate Gs from this location.
Golgi-localized β1ARs contribute tothe cAMP response
Nb80 can be used to block β2AR-mediated signalling when expressed in the cytoplasm at 
high levels, presumably through steric occlusion of the β2AR–Gs binding interface, although 
this requires Nb80 to be present at much higher concentration than when used as an 
activation biosensor28. Because Nb80 also recognizes activated β1AR, and β1AR engages 
Gs in a similar manner as β2AR, we reasoned that Nb80 might be useful for blocking 
β1AR–Gs coupling as well. We further reasoned that, because signal inhibition requires 
Nb80 to be present at high concentration, that it might be possible to use Nb80 as a location-
specific quencher through enforced proximity mediated by rapamycin-induced 
heterodimerization of the FK506-binding protein (FKBP) with the FKBP-rapamycin binding 
domain of FRAP (FRB)29. We fused FRB to the N-terminus of Nb80 (FRB-Nb80) and 
FKBP to a plasma membrane localization sequence derived from Lyn30 (PM-FKBP) or to 
the Golgi resident protein GalT (Golgi-FKBP). We verified rapamycin-induced recruitment 
of FRB-Nb80 specifically to the plasma membrane in cells co-expressing PM-FKBP (Fig. 
3a, top) and to Golgi membranes in cells co-expressing Golgi-FKBP (Fig. 3a, bottom). 
Recruiting FRB-Nb80 to the plasma membrane partially reduced the β1AR-Gs cellular 
cAMP response elicited by dobutamine (Fig. 3b, see also the time course in Supplementary 
Fig 4a). Chemical recruitment of FRB-Nb80 to Golgi membranes also produced a partial 
(and somewhat more pronounced) response inhibition (Fig. 3c, see also the time course in 
Supplementary Fig 4c). Verifying specificity, rapamycin produced no significant change in 
the cAMP response elicited by forskolin, a direct activator of adenylyl cyclase (Fig. 3d). 
Verifying that plasma membrane recruitment and Golgi recruitment of FRB-Nb80 suppress 
the cAMP response by inhibiting different pools of β1AR-Gs coupling, sotalol, a membrane-
impermeant antagonist, produced an additive inhibitory effect in cells with FRB-Nb80 
targeted to Golgi membranes but did not produce a significant additive effect in cells with 
FRB-Nb80 targeted to the plasma membrane (Fig. 3 b and c, see also Supplementary Fig 4a-
c). All together, these data suggest that Golgi-localized β1ARs can contribute significantly to 
the overall cAMP response.
Two modes of ligand access to the Golgi-localized β1AR pool
A key question raised by these observations is how ligands gain access to Golgi-localized 
β1ARs. Whereas dobutamine is a drug that is even more hydrophobic than alprenolol (logP 
3.4 compared to 3.1; pubchem.ncbi.nlm.nih.gov), a membrane-permeant ligand31, 
epinephrine is a relatively hydrophilic ligand (log P -1.4) and is membrane-impermeant. 
Therefore, while it seems likely that dobutamine can access the Golgi-localized receptor 
pool by passive diffusion, this cannot explain the ability of epinephrine to activate the Golgi 
pool (Fig. 4a, table). A clue to resolving this conundrum came from the observation that 
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epinephrine-induced activation of the Golgi-localized β1AR pool, assessed by Nb80-GFP 
recruitment, is blocked at low temperature (Supplementary Fig 5a-top row, Pearson’s 
coefficient=0.21) while dobutamine-induced recruitment still occurs (Supplementary Fig. 5a 
-bottom row, Pearson’s coefficient=0.51). Additionally, these ligands differ in the kinetics 
with which they activate the Golgi pool at 37˚C, with dobutamine driving Golgi-localized 
Nb80-GFP recruitment more rapidly (Supplementary Fig 5b). Together, these results support 
the hypothesis that epinephrine accesses the Golgi-localized β1AR pool in a different 
manner than dobutamine, requiring a time- and temperature-dependent process distinct from 
passive diffusion.
We first considered the possibility that epinephrine accesses the Golgi β1AR pool by fluid 
phase uptake and vesicular transport. This appeared unlikely because fluorescent 
Dextran-647, a fluid phase uptake marker, was not detected in Golgi membranes and instead 
accumulated in distinct endosomal membranes (Fig. 4b, Pearson’s coefficient=0.18). We 
next considered the possibility that epinephrine accesses the Golgi pool through a membrane 
transporter. An extraneuronal monoamine transporter (EMT), also known as an organic 
cation transporter-3 (OCT3), has been shown to facilitate intracellular uptake of epinephrine 
and other catecholamines in cardiac cells32,33. EMT/OCT3 expression was clearly detected 
in HeLa cells, whereas it was undetectable in HEK293 cells when assessed at either the 
mRNA or protein level (Supplementary Fig 5c and Fig. 4c, full images of blots are shown in 
supplementary Fig 6). EMT/OCT3 is a bidirectional transporter protein that localizes to both 
the plasma membrane and intracellular membranes in cardiac cells 33, and we observed a 
similar localization in HeLa cells (Fig. 4d and Supplementary Fig. 5d). Interestingly, the 
strong Golgi recruitment signal elicited bye pinephrinein HeLa cells (Fig. 1a) was not 
observed in HEK293 cells (Fig. 4e, middle row, Pearson’s coefficient=0.26). Nevertheless, 
dobutamine remained able to stimulate Nb80-GFP recruitment to Golgi membranes in both 
cell types (Fig. 4e, bottom row, Pearson’s coefficient=0.63). A characteristic feature of 
EMT/OCT3 is that its transport activity is blocked by corticosterone 34 and, remarkably, pre-
incubation of HeLa cells with corticosterone prevented epinephrine from driving visible 
Nb80-GFP recruitment to Golgi membranes while Nb80-GFP recruitment to the plasma 
membrane was unaffected (Fig. 4f, middle row, Pearson’s coefficient=0.15). By contrast, 
dobutamine-induced recruitment of Nb80-GFP to Golgi was not blocked in the same cells 
(Fig. 4f, bottom row, Pearson’s coefficient=0.68). All together, these data indicate that 
chemically distinct ligands can reach the Golgi membranes and activate Golgi-localized 
β1ARs using different mechanisms, diffusion in case of a hydrophobic agonist such as 
dobutamine and via extraneuronal monoamine transporters for the hydrophilic agonist 
epinephrine.
Epinephrine access to the Golgi-localized β1AR pool through a transporter-mediated process 
implies that this catecholamine is exposed to the cytoplasm for at least some time during 
transit. Cardiac cells express monoamine oxidase type A (MAO-A) on the mitochondrial 
outer membrane, and oxidative deamination catalysed by MAO-A is a major pathway of 
cytoplasmic epinephrine degradation35. HeLa cells are not known to express MAO-A, 
raising the question of whether the proposed route of epinephrine access to the Golgi-
localized β1AR pool is plausible in cells that express this enzyme. To begin to investigate 
this, we overexpressed in HeLa cells a GFP-tagged MAO-A construct and then used Nb80-
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mApple as a biosensor to assess activation of the Golgi pool. Epinephrine was still able to 
produce clearly detectable activation of the Golgi-localized β1AR pool in cells that were 
verified (by GFP fluorescence) to express recombinant MAO-A (Supplementary Fig. 5e). 
This indicates that transporter-dependent activation of Golgi-localized β1ARs is plausible 
even in cells expressing MAO-A, but leaves unresolved if Golgi activation occurs in 
response to endogenous levels of catecholamine release.
Selective inhibition by β-blocker drugs
We next considered the possibility that antagonists also differ in access to the Golgi-
localized β1AR pool. Differences between antagonists in hydrophobicity are known to affect 
drug access to the central nervous system according to drug permeability across the blood-
brain endothelial barrier36,37. We hypothesized that a similar principle affects antagonist 
access to the Golgi-localized β1AR pool. If so, antagonist drugs could provide an 
independent means to investigate the contribution of Golgi-localized β1ARs to the overall 
cellular signalling response. To test this we compared the ability of metoprolol and sotalol, 
β1AR antagonists that differ ~50-fold in relative hydrophobicity and thus are anticipated to 
differ in membrane-permeance (Fig. 5a, table). We tested relative access to each receptor 
pool by assessing effects on dobutamine-stimulated recruitment of Nb80-GFP.Metoprolol 
fully reversed Nb80-GFP recruitment to both the plasma membrane and Golgi membranes 
(Fig. 5b top panel, also see Supplementary Video 5) whereas sotalol selectively blocked 
recruitment to the plasma membrane but not to Golgi membranes, even when applied at 10-
fold higher concentration (Fig. 5b middle and bottom panel, also see Supplementary Video 
6). We then compared the ability of these antagonists to block the overall dobutamine-
stimulated cellular cAMP response. Preincubation of cells with either metoprolol or sotalol 
significantly inhibited the cellular response(Fig. 5c and d, first two bars), consistent with the 
ability of both drugs to block plasma membrane activation. However, sotalol produced less 
inhibition even when applied at very high concentration (Fig. 5c and d, light blue and grey 
bars 100μM and 5mM respectively). These findings further support the ability of Golgi-
localized β1ARs to contribute to the overall cellular cAMP response and, as both metoprolol 
and sotalol are presently used as ‘β–blockers’, they suggest that differential access to the 
Golgi-localized pool may contribute to functional selectivity among clinically relevant 
antagonists.
The Golgi β1AR pool can locally activate PKA
Protein Kinase A (PKA) holoenzymes are localized to distinct subcellular locations through 
their association to A-kinase anchoring proteins (AKAPs). Major PKA holoenzymes, type I 
and type II, are distinguished by the identity of their regulatory subunits (RI or RII 
isoforms)38, with type II holoenzymes known to localize to the Golgi apparatus39.PKA 
activation by cAMP causes the Cα catalytic subunit to dissociate into the cytoplasm while 
RII regulatory subunits remain Golgi-associated40-42. To test whether activation of Golgi-
localized β1AR can cause PKA activation on the Golgi membrane, we imaged both subunits 
of a type II holoenzyme (Cα-YFP and RIIβ-mCherry) in living cells. Dobutamine induced 
the rapid translocation of the Cα subunit from Golgi membranes to the cytoplasm in β1AR-
expressing HeLa cells, whereas the RII subunit remained Golgi-localized (Fig 6a and d, blue 
line; Supplementary Video 7). We then asked if this translocation can be elicited specifically 
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by activation of the Golgi-localized β1AR pool. To test this we compared the effect of 
metoprolol and sotalol on dobutamine-induced PKA Cαtranslocation. The membrane-
permeant antagonist metoprolol fully blocked PKA Cα Golgi translocation (Fig 6c and d, 
red line; supplementary Video 8) whereas sotalol did not, even when applied at very high 
concentration (5mM) (Fig 6b and d, grey line; supplementary Video 9). Further, 
dobutamine-induced dissociation of Cα from Golgi membranes was delayed in sotalol-
treated cells, suggesting that plasma membrane and Golgi-localized β1AR pools promote 
activation of Golgi-localized PKA with distinct kinetics.
Discussion
The present findings provide direct evidence for adrenergic signalling from the Golgi 
apparatus and demonstrate that catecholamines can reach the internal pool to initiate 
canonical β1AR-Gs signalling from this location. Thus Golgi-localized β1ARs do not simply 
represent intermediates for later delivery to the plasma membrane, but they also comprise a 
functional signalling pool at this location. Selective inhibition of β-AR-Gs coupling by 
chemical recruitment of nanobody independently verifies the signalling potential of the 
Golgi-localized β1AR pool and introduces a new approach for functionally interrogating 
compartmentalized GPCR signalling more generally.
The present study provides evidence for two routes of ligand access to the Golgi localized 
β1AR pool. Drugs such as dobutamine access the Golgi pool by passive diffusion, 
determined largely by degree of lipophilicity43. The catecholamine agonist epinephrine is 
relatively hydrophilic and membrane-impermeantlig and whose access to the Golgi-localized 
β1AR pool requires OCT3, a member of the extraneuronal monoamine transporter (EMT) / 
organic cation transporter (OCT) family that is already known to function in cellular 
catecholamine uptake32. OCT3 exists both in the plasma membrane and internal membranes 
and can operate in a bidirectional manner43. Whether OCT3 is fully responsible for 
epinephrine uptake to the Golgi-localized β1AR pool, or if additional transporter(s) are also 
required or contribute, is an interesting question for future study. Another interesting 
question that remains to be answered is whether the transporter-dependent ligand access 
route is relevant to native β1AR signalling elicited by endogenously produced 
catecholamines or represents a drug-specific target.
The effect of different antagonists on the Golgi-localized signal has interesting implications 
for pharmacology.We speculate that differential drug access to the Golgi pool contributes to 
diversity in the clinical effects of existing β blocker drugs. Evidence suggests that 
metoprolol and propranolol, both hydrophobic antagonists, cause reduction of chronotropic 
(heart rate) and inotropic (force of contraction) responses, whereas sotalol can only cause a 
reduction in the heart rate44,45. The present study has focused on cAMP signalling but we 
note that heterotrimeric G proteins are thought to also regulate membrane trafficking 
processes, both at the Golgi and in endosomes11,25,46,47. Thus it is possible that differential 
drug effects on Golgi-localized β1AR activation may also have trafficking consequences.
The β2AR, a closely homologous adrenergic receptor, can mediate Gs signalling from 
endosomes as well as the plasma membrane 3, with the endosome-initiated signal 
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preferentially promoting downstream cAMP-dependent transcription4. It remains unknown 
if Golgi-localized β1ARs also have distinct functions compared to plasma membrane 
localized β1ARs. Although both β1ARs and β2ARs couple to Gs and activate adenylyl 
cyclase, they have different effects on physiological responses such as regulating heart rate 
(chronotropic), contractility (inotropic) and the rate of relaxation (lusitropic) in cardiac 
myocytes8. β1AR plays a major role in regulating, inotropic and lusitropic effects, whereas 
β2AR mainly regulates chronotropic effects and have significantly smaller inotropic effect 
and no lusitropic effect48,49. The underlying reasons for these distinctions remain unclear 
but there is already evidence that differences in downstream consequences of β1AR versus 
β2AR activation can result from differences in receptor localization between lateral 
microdomains of the plasma membrane50. The present results expand this concept by 
revealing that β1AR and β2AR initiate signalling from different internal membrane 
compartments and these are differentially accessible by ligands.
ONLINE METHODS
Cell Culture, cDNA constructs and transfection
HeLa, HEK293 and H9C2 cells (purchased from ATCC as authenticated lines CCL-2, 
CRL-1573 and CRL 1446 respectively) were grown in Dulbecco’s minimal essential 
medium supplemented with 10% Fetal Bovine Serum (FBS)(UCSF Cell Culture Facility) 
without antibiotics. Cell cultures were free of mycoplasma contamination. pVenus-FRB-
Nb80 was created by amplifying Nb80 and FRB from Nb80-GFP3, and pC4-RHE plasmid 
(ARIAD Pharmaceuticals), using 5’-
CGAATCTCAAAGGATAGTGCTGGTAGTGCTGGTGGACAGGTGCA -3’; 5’- 
GGATCCTCATGAGGAGACGGTGACCTGGGT -3’ and 5’- 
GAATTCAATCCTCTGGCATGAGATGTGGCATGAAGGCCTGGAAGA -3’; 5’- 
CGAATCTCAAAGGATAGTGCTGGTAGTGCTGGTGGACAGGTGCA -3 primers 
respectively, such that it contained the linker sequence 
GATAGTGCTGGTAGTGCTGGTGGAC, and inserted into the pVenus-C1 vector using 
EcoRI and BamH1. FKBP-GalT-mApple was created by amplifying FKBP and GalT from 
KDELr-FKBP47 and GalT-mCherry plasmids (a generous gift from Dr.Farese lab), using 5’- 
CATGCTAGCGCCGCCACCATGGGAGTGCAGGTGGAAACCAT-3’, 5’-
GAGCTCGAGACCAGCACTACCAGCACTATCCTCCAGCTTCAGCAGCTCCACG3’ 
and 5’- GCTCAAAGCTTGCCGCCACCGGAAGGCTTCGGGAGCCG-3’, 5’- 
ACCGGATCCTTAGGCCCCTCCGGTCCGGAGCTCCCCG-3’ primers, respectively and 
inserted into the pmApple-N1 vector using NheI, XhoI for FKBP and HindIII and BamHI 
for GalT. Mouse PKA Cα-YFP and PKA RIIβ-mCherry constructs were generous gits from 
Dr. Xiang lab. Transfections were performed using Lipofectamine 2000 (Invitrogen) 
according to the manufacturer’s instructions. ADRB1-2 (5’-
CGUCCGUCGUCUCCUUCUATT-3’) and 3 (5’GGGUGUUCCGCGAGGCCCATT-3’) 
siRNAs (Qiagen) were used to knockdown β ARs. siRNA transfections were performed 
using RNAiMax (Invitrogen) according to the manufacturer’s instructions. Flag tagged 
human βAR constructs were labelled with Alexa-647 or 555-conjugated M1 anti-FLAG 
monoclonal antibody (Sigma) as described previously 51. Anti-SLC22A3 antibody (abcam-
ab124826) and anti-beta 1 adrenergic receptor antibody (abcam-ab3442) were used to detect 
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endogenous levels of EMT/OCT3 and β1AR, respectively. Anti Gαs/olf antibody (SC-383) 
was used to detect endogenous Gαs in HeLa cells.
Live-cell confocal imaging
Live cell imaging was carried out using Yokagawa CSU22 spinning disk confocal 
microscope with a 100 ×, 1.4 numerical aperture, oil objective and a CO2 and 37 °C 
temperature-controlled incubator. A 488, 568 nm and 640 Coherent OBIS laser were used as 
light sources for imaging GFP and Flag signals, respectively. Cells expressing both Flag-
tagged receptor (2μg) and the indicated nanobody–GFP (100ng) were plated onto glass 
coverslips. Receptors were surface labelled by addition of M1 anti-Flag antibody (1:1000, 
Sigma) conjugated to Alexa 555 (A10470, Invitrogen) to the media for 10 min, as described 
previously. Indicated agonist (isoprenaline-Sigma, epinephrine-Sigma, dobutamine-Sigma), 
or antagonist (ICI 118551- TOCRIS, metoprolol-Sigma, sotalol-Sigma) were added and 
cells were imaged every 3 s for 20 min in DMEM without phenol red supplemented with 30 
mM HEPES, pH 7.4 (UCSF cell culture facility). Time-lapse images were acquired with a 
Cascade II EM-charge-coupled device (CCD) camera (Photometrics) driven by Micro-
Manager 1.4 (http://www.micro-manager.org).
Fixed-cell confocal imaging
Cells were permeabilized with saponin to reduce the cytoplasmic background, as described 
previously52. Briefly, transfected cells with indicated constructs or non-transfected H9C2 
cells were permeabilized with 0.05% saponin (Sigma) in PEM buffer (80mM K-Pipes, pH 
6.8, 5 mM EGTA, 1mM MgCl2) for 5 min on ice. Cells were then fixed with 3% 
paraformaldehyde in PBS for 10 min and then quenched with 50mM Nh4Cl in PBS for 15 
min. Primary antibodies (β1AR antibody (abcam-ab3442) 1:100, M1 anti-Flag mouse 
antibody (1:1000, Sigma) conjugated to Alexa 647, anti GFP mouse antibody (1:500, 
Sigma) and anti GFP Rabbit antibody (1:500, Life Technologies) were diluted in PBS 
supplemented with 0.05% saponin. Confocal images were taken using Yokagawa CSU22 
spinning disk confocal microscope with a 100x or 60x 1.4 numerical aperture, oil objective.
Image analysis and statistical analysis
Images were saved as 16 bit TIFF files. Quantitative image analysis was carried out on 
unprocessed images using ImageJ software (http://rsb.info.nih.gov/ij). Analysis of Nb80–
GFP intensity profile along the segmented was carried out using the ImageJ plot profile 
function. For estimating kinetics of Nb80–GFP recruitment at the Golgi membrane over 
time in confocal images, individual cells were selected manually and average fluorescence 
intensity was measured at the Golgi area in each frame and normalized to the fluorescence 
intensity of the Golgi marker. A blank area of the image lacking cells was used to estimate 
background fluorescence. For estimating kinetics of PKACα YFP translocation from the 
Golgi membrane over time in confocal images, individual cells were selected manually and 
average fluorescence intensity was measured at the Golgi area in each frame and normalized 
to the fluorescence intensity of the PKA RIIβ-mCherry. A blank area of the image lacking 
cells was used to estimate background fluorescence. Co-localization analysis at the Golgi 
was estimated by calculating the Pearson’s coefficient between the indicated image channels 
with the Golgi marker channel, using the co-localization plug-in for ImageJ (Coloc2).For 
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visual presentation (but not quantitative analysis) image series were processed using Kalman 
stack filter in ImageJ.P values are from two-tailed unpaired Student’s t-tests calculated using 
Prism 6.0 software (GraphPad Software).
Luminescence-based cAMP assay
HEK 293 cells stably expressing β1AR were transfected with a plasmid encoding a cyclic-
permuted luciferase reporter construct, (pGloSensor-20F, Promega) and luminescence values 
were measured, as described previously3. Briefly, cells were plated in 24-well dishes 
(~200,000 cells per well) in 500 μl DMEM without phenol red/no serum and equilibrated to 
37 °C in a light-proof cabinet and images were collected every 10 s using a CCD camera 
(Hamamatsu C9100-13) and Micro-Manager (http://www.micro-manager.org).MATLAB 
(MathWorks)scripts were used to calculate integrated luminescence intensity and 
background subtraction.In rapamycin heterodimerization experiments, cells were pre-
incubated with 1μM rapamycin (Sigma) for 15 min. 5μM forskolin was used as a reference 
value in each multi-well plate and for each experimental condition. The average 
luminescence value (measured across duplicate wells) was normalized to the maximum 
luminescence value measured in the presence of 5μM forskolin. For rapamycin treated cells, 
the average luminescence value was normalized to the maximum luminescence value 
measured in the presence of 5μM forskolin and 1μM Rapamycin.
Quantitative real-time PCR
Total RNA was extracted from samples with RNeasy Mini Kit (Qiagen). Reverse 
transcription was carried out using SuperScript III RT (Invitrogen), mix of oligo (dT). The 
resulting cDNA was used for quantitative PCR with StepOnePlus (ABI). SYBER Select 
Mastermix (Invitrogen) was used for EMT/OCT3 expression measurements using 
5’CCTTGTCTGTGTCAATGCGTGG3’ and 5’CCAACACCAAGGCAGGATAGCA3’ 
primers. All levels were normalized to the levels of a housekeeping gene, GAPDH.
Western blotting
Cells from HEK293, HeLa, H9C2 and neonatal cardiac myocytes were lysed in extraction 
buffer (0.2% Triton X-100, 50mM NaCl, 5mM EDTA, 50mM Tris at pH 7.4 and complete 
EDTA-free protease inhibitor cocktail (Roche). Extracts were mixed with SDS sample buffer 
for degradation. The proteins were resolved by SDS-PAGE and transferred to nitrocellulose 
membrane and blotted for anti-β1AR (ab-3442- 1:1000), anti-SLC22A3 (ab124826-1:1000) 
or GAPDH (1:10,000) antibodies to detect β1AR, EMT/OCT3 and GAPDH expression by 
horseradish-peroxidase-conjugated rabbit IgG, sheep anti-mouse and rabbit IgG (1:10,000 
Amersham Biosciences) and SuperSignal extended duration detection reagent (Pierce).
Internalization Assay by Flow Cytometry
Internalization assay was carried out on HeLa cells transiently expressing Flag-tagged β1AR 
or β2AR. Cells were treated either with 10μM isoproterenol alone for 20min to promote 
endocytosis or pre-treated with 30μM Dyngo-4a for 15min to block endocytosis and then 
10μM isoproterenol for 20 min at 37°C. Surface receptors were labelled by M1 anti-Flag 
antibody conjugated to Alexa 647 (Sigma, 1:1000) for 45min at 4°C. Cells were then 
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collected in cold PBS and the fluorescence intensity profiles of cell populations (10,000 cells 
per sample) were measured using a FACS-Calibur instrument (BD Biosciences). In each 
experiment, triplicate samples were analysed for each condition. Experiments were carried 
out three times on three separate days.
Data availability
Our research resources, including methods, cells and protocols are available upon request. 
All reagents developed, such as FRB and FKBP constructs, as well as detailed methods will 
be available upon request. The corresponding author adheres to the NIH Grants Policy and 
Sharing of Unique Research Resources.
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Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Golgi localized β1AR achieve an activated conformation upon extracellular ligand 
application
a, Representative β1AR expressing HeLa cell showing Nb80-GFP (green) and Golgi Marker 
(GalT-mRFP) (red) localization at the indicated time after 10 μM epinephrine addition (n = 
18 cells, Pearson’s coefficient=0.67, 4 biological replicates, left); Representative individual 
Nb80–GFP line scans (arrowheads and arrow indicate plasma membrane and Golgi 
recruitment, respectively, right). b, Representative β1AR expressing HeLa cell showing 
Nb80–GFP (green) and Golgi Marker (GalT-mRFP) (red) localization at the indicated time 
after 10 μM dobutamine addition, cells were pre-treated with 10 μM ICI118551 (β2AR 
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selective antagonist) 20 min before addition of dobutamine (n = 25 cells, Pearson’s 
coefficient=0.71, 7 biological replicates). c, Confocal images showing permeabilized cells 
labelled with conjugated Alexa-555 flag tagged-β1AR (red) and Nb80-GFP (green) 
localization at the indicated time after 10 μM dobutamine addition, cells were pre-treated 
with 10 μM ICI118551 (β2AR selective antagonist) 20 min before addition of dobutamine 
(n=19 cells, 2 biological replicates, arrow indicate Golgi-localized β1AR). d, Comparison of 
β2AR and β1AR internalization after 20 min 10 μM epinephrine treatment in HeLa cells by 
flow cytometry with and without Dyngo-4a treatment (bars represents mean ± s.e.m., 3 
biological replicates). e, Representative surface-labelled β1AR expressing HeLa cell pre-
treated with 30 μM Dyngo-4a (dynamin inhibitor) and labelled with conjugated Alexa-647 
flag tagged-β1AR (cyan), Nb80-mApple (red) and Golgi Marker (GalT-GFP) (green) at the 
indicated time after 10 μM epinephrine addition (n = 10 cells, Pearson’s coefficient=0.5, 4 
biological replicates, Yellow arrowheads indicates Golgi localization). Scale bars, 10 μm.
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Figure 2. Golgi-localized β1AR activates Gs-mediated cAMP response
a, Confocal image of HeLa cell showing Gs-turquoise (top panel) or endogenous Gs (bottom 
panel) in green and Golgi marker (GalT-mRFP) in red (representative of n = 12 and 35 cells, 
Pearson’s coefficient=0.62 and 0.48 respectively, 2 biological replicates). Arrow and 
arrowheads indicate Gs plasma membrane and Golgi localization.b, Confocal images 
showings surface-labelled β1AR (cyan), Nb37–GFP (green) and GalT-mRFP (red) at 
indicated time points after agonist addition (representative of n = 12 cells, Pearson’s 
coefficient=0.33, 3 biological replicates). Arrow and arrowhead indicate Nb37-GFP 
recruitment to the PM and Golgi, respectively. Insets show higher magnification. c. Top, 
confocal images of H9C2 cells treated with control or β1AR siRNA and labelled with anti-
β1AR (green) and GalT-mRFP (red) (representative of n = 44 and 46 cells respectively, 
Pearson’s coefficient=0.55 and0.26 from 5 and 3 biological replicates). Bottom-left, average 
Pearson’s coefficient of anti-β1AR antibody (green) and GalT-mRFP (red) in control or 
β1AR knockdown cells (bars represents mean ± s.e.m., 3 biological replicates; p<0.0001 by 
two-tailed unpaired t-test). Bottom-right, representative immunoblots from control and 
β1AR knockdown cells blotted for anti-β1AR antibody and GAPDH.Full images shown in 
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Supplementary Figure 3a.Average knockdown was 82% of control (mean±SD, n=2). d. 
Confocal images of H9C2 cells expressing Nb80-GFP or Nb37-GFP before and after 10μM 
dobutamine treatment using anti-β1AR antibody (cyan) (representative of n = 24,16, 20 and 
20 cells respectively, 3 biological replicates, arrows and arrowheads indicate plasma 
membrane and Golgi, respectively).Scale bar, 10 μm.
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Figure 3. Rapamycin-inducible recruitment of Nb80 blocks β1AR-Gs coupling and inhibits Gs-
mediated cAMP response at both the plasma membrane and the Golgi
a, Representative images showing pVenus-FRB-Nb80 localization before and after 
rapamycin addition in HeLa cells expressing PM-FKPB (11-lyn-FKBP), top; or Golgi-
FKBP (FKBP-GalT), bottom; (arrowhead and arrow shows plasma membrane and Golgi 
recruitment of pVenus-FRB-Nb80). b, Top, model for blocking β1AR-Gs coupling at the 
plasma membrane after recruitment of pVenus-FRB-Nb80. Bottom, forskolin-normalized 
β1AR-mediated cAMP response in the absence (dark blue bar) or presence (light blue bar) 
of 15 min pre-treatment of 1 μM rapamycin, rapamycin plus 100μM sotalol (red bar) (mean 
± s.e.m., n = 4 biological replicates). Statistical significance was tested using two tailed 
unpaired t test (p =0.0008 and 0.3744 respectively). c, Top, model for blocking β1AR-Gs 
coupling at the Golgi membrane after recruitment of pVenus-FRB-Nb80. Bottom, forskolin-
normalized β1AR-mediated cAMP response in the absence (dark blue bar) or presence (light 
blue bar) of 15 min pre-treatment of 1 μM rapamycin or rapamycin plus 100μM sotalol (red 
bar) (mean ± s.e.m., n = 7 biological replicates). Statistical significance was tested using two 
tailed unpaired t test (p <0.0001 and 0.0001, respectively). d. Effect of 1μM rapamycin on 
forskolin-mediated cAMP response (n=10 biological replicates). Scale bars, 10 μm.
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Figure 4. Epinephrine accesses the Golgi-localized β1AR pool via corticosterone-sensitive 
membrane transport
a, Examples of membrane permeant and membrane impermeant β adrenergic agonists. b, 
Confocal image of HeLa cell expressing β1AR and Nb80-mApple, showing distinct 
localization of Nb80-mApple (red) and Dextran-647 (green) after pulse-chased labelling 
with Dextran-647 for 20 min and 10μM epinephrine treatment at the same time (n = 25 cells, 
Pearson’s coefficient=0.18, 3 biological replicates).c. Lysates from indicated cells were 
probed with anti-SLC22A3 (anti-EMT/OCT3) and anti- GAPDH antibody to control for 
equal loading and expression. Full images shown in Supplementary Figure 6. d. Confocal 
image of HeLa cells stained with anti-SLC22A3 (anti-EMT/OCT3) showing plasma 
membrane (yellow arrow) and intracellular membrane (yellow arrowhead) localization (n = 
26 cells, 3 biological replicates). e. Representative β1AR expressing HEK293 cell showing 
Irannejad et al. Page 20
Nat Chem Biol. Author manuscript; available in PMC 2017 December 18.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Nb80–GFP (green) and Golgi Marker (GalT-mRFP) (red) localization at the indicated time 
after 10 μM epinephrine (middle row, Pearson’s coefficient=0.26) and dobutamine (bottom 
row, Pearson’s coefficient=0.63) addition (n = 11 cells, 2 biological replicates). f. 
Representative β1AR expressing HeLa cell showing Nb80–GFP (green) and Golgi Marker 
(GalT-mRFP) (red) localization at the indicated time after 10 μM epinephrine (middle row, 
Pearson’s coefficient=0.15) and dobutamine (bottom row, Pearson’s coefficient=0.68) 
addition. Cells were pre-treated with 10μM corticoesterone for 15 min (n = 12 cells, 3 
biological replicates). Scale bars, 10 μm.
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Figure 5. Pharmacological manipulations differentially regulate β1AR compartmentalized 
signalling
a, Examples of membrane permeant and membrane imperment β adrenergic antagonist and 
their effects on plasma membrane and Golgi signalling. b, Confocal image frames of 
activated β1AR expressing HeLa cells with 10 μM dobutamine showing Nb80-GFP (green) 
and Golgi marker colocalization followed by reversal with 10 μM Metoprolol (top) (n= 3 
cells, 3 biological replicates) or 100μM Sotalol (middle) (n= 5 cells, 3 biological replicates) 
or 5mM Sotalol (bottom) addition at indicated time points (arrowheads indicate Golgi 
localization of Nb80-GFP after addition of 100μM and 5mM Sotalol for 20min). c, Time 
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course and d. maximum forskolin-normalized β1-AR-mediated cAMP response by 10 μM 
dobutamine (dark blue), pre-treated with 10 μM Metoprolol (red), 100 μM sotalol (light 
blue), 5mM sotalol (grey) (mean ± s.e.m., n=3 biological replicates). Statistical significance 
was tested using two tailed unpaired t test (p <0.0001, p =0.0035 and p =0.034 respectively). 
Scale bars, 10 μm.
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Figure 6. Pharmacological manipulations differentially regulate β1AR-mediated PKA activation 
on the Golgi
a. Confocal image frames of β1AR expressing HeLa cells treated with 10 μM dobutaine at 
indicated time points (n= 7 cells, 4 biological replicates). b. Confocal image frames of β1AR 
expressing HeLa cells pre-treated with 5mM sotalol and upon addition of 10μM dobutaine at 
indicated time points (n= 9 cells, 4 biological replicates). c. Confocal image frames of β1AR 
expressing HeLa cells pre-treated with 10μM metoprolol and upon addition of 10μM 
dobutamine at indicated time points (n= 5 cells, 4 biological replicates). d. Kinetics of PKA 
Cα-YFP translocation from the Golgi membrane in cells treated with 10μM dobutamine 
(blue), 10μM metoprolol+10μM dobutamine (red) or 5mM sotalol+ 10μM dobutamine; the 
fluorescent intensity of PKA Cα-YFP was normalized by PKA RIIβ-mCherry fluorescent 
(n= 7, 5 and 9, 4 biological replicates) (see methods).Scale bars, 10 μm.
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